Search results
Showing 6316 to 6330 of 8215 results
The government has today (1 December 2025) announced that it will increase the thresholds NICE uses in evaluations of new medicines to decide which are cost-effective for use in the NHS.
NICE's prioritisation process explained – what healthtech developers need to know
Understand why we're prioritising key topic areas for evaluation and what it means for innovators
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
Process guide for adoption support resources for health technologies (PMG23)
This process and methods guide has been withdrawn.
This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.
This guidance has been updated and replaced by NICE guideline NG130.
Myocardial infarction with ST-segment elevation: acute management (CG167)
This guideline has been updated and replaced by NICE guideline NG185.
Acute kidney injury: prevention, detection and management (CG169)
This guidance has been updated and replaced by NICE guideline NG148.
Dyspepsia: Management of dyspepsia in adults in primary care (CG17)
This guidance has been updated and replaced by NICE guideline CG184.
This guideline has been updated and replaced by NICE guideline NG123.
This guideline has been updated and replaced by NICE guideline NG185.
This guideline has been updated and replaced by the NICE guideline on intrapartum care (NG235).
This guidance has been updated and replaced by NICE guideline CG82.
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)
This guideline has been updated and replaced by NICE guideline NG115.
Type 2 diabetes foot problems: Prevention and management of foot problems (CG10)
This guidance has been updated and replaced by NICE guideline NG19.